Literature DB >> 28569348

Black Tar Heroin Skin Popping as a Cause of Wound Botulism.

Ihtesham A Qureshi1, Mohtashim A Qureshi2, Mohammad Rauf Afzal2, Alberto Maud2, Gustavo J Rodriguez2, Salvador Cruz-Flores2, Darine Kassar2.   

Abstract

BACKGROUND: Botulism is a rare potentially fatal and treatable disorder caused by a bacteria-produced toxin that affects the presynaptic synaptic membrane resulting in a characteristic neuromuscular dysfunction. It is caused by either the ingestion of the toxin or the bacteria, inhalation, or wound infection. We present our observations with a descriptive case series of wound botulism secondary to black tar heroin (BTH) injection.
METHODS: We report a retrospective single-center case series of 15 consecutive cases of wound botulism presenting to University Medical Center of El Paso. Medical records where reviewed to obtain demographic information, clinical presentation, treatment, and outcome.
RESULTS: We identified fifteen patients with mean age of 47 years: twelve men, and three women. All had administered BTH through skin popping and had abscesses in the administration areas. By history, the most common symptoms were dysphagia (66%), proximal muscle weakness of upper and lower extremity (60%), neck flexor muscle weakness (33%), ophthalmoplegia (53%), bilateral ptosis (46%), dysarthria (53%), double vision (40%), blurred vision (33%), and dry mouth (20%). During the examination, the most common features noted were: proximal muscle weakness of upper and lower extremities (73%), ophthalmoplegia (53%), ptosis (46%). In patients with documented wound botulism, the pupils were reactive in 46%. All patients required mechanical ventilation and were treated with the trivalent antitoxin. Eleven patients (73.3%) were discharged home, two were transferred to a skill nursing facility, and two were transferred to long-term acute care facility.
CONCLUSION: In our patients, BTH injection, involving the action of injecting under the skin acetylated morphine derivatives (mostly 6-monoacetylmorphine and 3-monoacetylmorphine), was associated with the development of botulism. The availability of BTH at the US-Mexican border is not surprising since it is frequently produced in Latin America. Its association with the development of botulism should be recognized early to allow a prompt diagnosis and treatment with the antitoxin. A clinical feature worth noting is the presence of normal pupillary light reflex in nearly half of patients. Therefore, the presence of a normal pupillary response does not exclude the presence of wound botulism.

Entities:  

Keywords:  Black tar heroin; Early diagnosis; Skin popping; Symptoms; Wound botulism

Mesh:

Substances:

Year:  2017        PMID: 28569348     DOI: 10.1007/s12028-017-0415-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  18 in total

1.  Wound botulism in the UK and Ireland.

Authors:  Moira M Brett; Gill Hallas; Obioma Mpamugo
Journal:  J Med Microbiol       Date:  2004-06       Impact factor: 2.472

2.  Wound botulism from heroin skin popping.

Authors:  Larry E Davis; Molly K King
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

3.  A 38-year-old woman with heroin addiction, ptosis, respiratory failure, and proximal myopathy.

Authors:  Thejeswi Pujar; Irene M Spinello
Journal:  Chest       Date:  2008-10       Impact factor: 9.410

4.  Wound botulism resulting from heroin abuse: can you recognize it?

Authors:  Laura Abavare; Charles Abavare
Journal:  J Emerg Nurs       Date:  2011-04-22       Impact factor: 1.836

5.  Epidemiologic, clinical and laboratory aspects of wound botulism.

Authors:  M H Merson; V R Dowell
Journal:  N Engl J Med       Date:  1973-11-08       Impact factor: 91.245

6.  Rapid geographical clustering of wound botulism in Germany after subcutaneous and intramuscular injection of heroin.

Authors:  Norbert Galldiks; Silke Nolden-Hoverath; Christoph M Kosinski; Ulrike Stegelmeyer; Sylvia Schmidt; Christian Dohmen; Jens Kuhn; Kathrin Gerbershagen; Heiko Bewermeyer; Peter Walger; Rolf Biniek; Michael Neveling; Andreas H Jacobs; Walter F Haupt
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

7.  Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988.

Authors:  B A Woodruff; P M Griffin; L M McCroskey; J F Smart; R B Wainwright; R G Bryant; L C Hutwagner; C L Hatheway
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

8.  Botulism and botulism-like illness in chronic drug abusers.

Authors:  K L MacDonald; G W Rutherford; S M Friedman; J R Dietz; B R Kaye; G F McKinley; J H Tenney; M L Cohen
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

9.  Heroin in brown, black and white: structural factors and medical consequences in the US heroin market.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2008-10-21

10.  Botulism in injecting drug users, Dublin, Ireland, November-December 2008.

Authors:  J Barry; M Ward; S Cotter; J Macdiarmada; M Hannan; B Sweeney; K A Grant; P McKeown
Journal:  Euro Surveill       Date:  2009-01-08
View more
  3 in total

Review 1.  Review of Neurologic Comorbidities in Hospitalized Patients With Opioid Abuse.

Authors:  Kevin R Nelson; Katelyn Dolbec; William Watson; Hanwen Yuan; Mam Ibraheem
Journal:  Neurol Clin Pract       Date:  2021-12

2.  Is black tar heroin use associated with wound botulism? A report of two Hispanic patients.

Authors:  Ihtesham A Qureshi; Mohtashim A Qureshi; Anantha-Ramana Vellipuram; Darine Kassar
Journal:  Clin Case Rep       Date:  2018-05-29

3.  Bulbar Muscle Weakness in the Setting of Therapeutic Botulinum Injections.

Authors:  Jacob Lentz; Daniel Weingrow
Journal:  Clin Pract Cases Emerg Med       Date:  2018-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.